Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Clinical trial NCT02964273 · COMPLETED
Trial details
- NCT number
- NCT02964273
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-23
- Primary completion
- 2021-11-17
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.